Advertisement
Screener

BIOAGE LABS, INC. (BIOA) Authorized Dilution

BIOAGE LABS, INC. Authorized Dilution

Share-issuance capacity and approved equity plans, with the disclosed share class, period, approval and expiry. Gross charter headroom is authorized minus issued shares, not a forecast. Equity plan reserves may use weighted counting rules, overlap charter capacity, and must not be added to it. Outstanding awards, future grants, and proposed approvals are distinct. * denotes calculated capacity.

As ofAuthorization / planShare classAuthorized / approved limit (shares)Issued shares / outstanding awards (shares)Remaining capacity (shares / reserve units)Approval statusApproval dateExpiry / conditionsBasis / limitationsSource

Similar stocks

Stock NameCountryMarket CapPE Ratio
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Vogenx, Inc. (VOGX)United States$0.355B
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58